Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Thomas James Doyle

Svp, Finance & Accounting at Kura Oncology, Inc. (KURA)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $160K

Reported trades

Filed Stock Type Shares Price Value Since
Sep 29SEC KURAKura Oncology, Inc. Sell 4,607142,428 held (−3%) $10.50 $48K +1.0%
Jan 27SEC KURAKura Oncology, Inc. Sell 2,226150,083 held (−1%) $8.46 $19K +25.3%
Jan 27SEC KURAKura Oncology, Inc. Sell 1,114148,969 held (−1%) $8.46 $9K +25.3%
Jan 27SEC KURAKura Oncology, Inc. Sell 695148,274 held (−0%) $8.46 $6K +25.3%
Jan 27SEC KURAKura Oncology, Inc. Sell 2,226146,048 held (−2%) $8.46 $19K +25.3%
Jan 27SEC KURAKura Oncology, Inc. Sell 881145,167 held (−1%) $8.46 $7K +25.3%
Nov 14SEC KURAKura Oncology, Inc. Sell 4,539130,257 held (−3%) $11.18 $51K -5.2%